FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W260545907> ?p ?o ?g. }

• W260545907 endingPage "7863" @default.
• W260545907 startingPage "7859" @default.
• W260545907 abstract "Nicotinamide phosphorybosiltransferase (NAMPT) plays an important role in the regulation of cellular growth, angiogenesis, and apoptosis in mammalian cells. NAMPT overexpression has been recently found in colorectal, breast, prostatic, gastric, esophageal, pancreatic cancers, and specific NAMPT inhibitors might be adjuvant therapeutic modalities. In this study, we analyzed NAMPT expression in 40 malignant and in 67 benign thyroid tissue samples using qPCR. We also investigated relationships between NAMPT expression and survivin/survivin splicing variants DEx3 and 2B expressions. NAMPT expression was significantly higher in thyroid cancers (P < 0.0001), and it was positively correlated with tumor stage (P = 0.0012; r = 0.493). NAMPT expression was significantly higher in tumors staged pT3 or pT4 (16 cases) than in tumors staged pT1 or pT2 (24 cases) (P = 0.0106). Metastases to the lymph nodes were found in 12 out of 40 cases, and NAMPT expression was higher in the metastatic group (P = 0.0258). Multifocality was not associated with higher NAMPT expression (P = 0.3451). NAMPT expression in thyroid cancers significantly correlated with survivin and with survivin splice variant DEx3 expressions (P < 0.0001; r = 0.624 and P = 0.0239; r = 0.357, respectively). There was no correlation between NAMPT and survivin 2B expressions (P = 0.3508). This is the first study demonstrating NAMPT overexpression in thyroid malignancies using quantitative RT-PCR. Moreover, it shows that NAMPT is upregulated in patients with more advanced tumor stage and metastatic disease which may prove to be clinically relevant. Further studies are needed to explain the role of NAMPT in thyroid cancer biology and the possible use of NAMPT inhibitors in thyroid cancer." @default.
• W260545907 created "2016-06-24" @default.
• W260545907 creator A5000899916 @default.
• W260545907 creator A5010799497 @default.
• W260545907 creator A5014711416 @default.
• W260545907 creator A5019040298 @default.
• W260545907 creator A5075727656 @default.
• W260545907 creator A5088703623 @default.
• W260545907 creator A5089571215 @default.
• W260545907 date "2015-05-07" @default.
• W260545907 modified "2023-10-16" @default.
• W260545907 title "Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression" @default.
• W260545907 cites W133339115 @default.
• W260545907 cites W1806378671 @default.
• W260545907 cites W1964346005 @default.
• W260545907 cites W1964939500 @default.
• W260545907 cites W1970688610 @default.
• W260545907 cites W1972855519 @default.
• W260545907 cites W1976616566 @default.
• W260545907 cites W1981106431 @default.
• W260545907 cites W1985075679 @default.
• W260545907 cites W1992969032 @default.
• W260545907 cites W1996128391 @default.
• W260545907 cites W2004224039 @default.
• W260545907 cites W2005629883 @default.
• W260545907 cites W2014748943 @default.
• W260545907 cites W2016158899 @default.
• W260545907 cites W2023747218 @default.
• W260545907 cites W2033882181 @default.
• W260545907 cites W2034260699 @default.
• W260545907 cites W2055797474 @default.
• W260545907 cites W2073485652 @default.
• W260545907 cites W2076186796 @default.
• W260545907 cites W2079186201 @default.
• W260545907 cites W2086672744 @default.
• W260545907 cites W2089992334 @default.
• W260545907 cites W2098274411 @default.
• W260545907 cites W2119501407 @default.
• W260545907 cites W2125997801 @default.
• W260545907 cites W2131253478 @default.
• W260545907 cites W2134939903 @default.
• W260545907 cites W2138902181 @default.
• W260545907 cites W2145463957 @default.
• W260545907 cites W2164927998 @default.
• W260545907 cites W2168230466 @default.
• W260545907 cites W2321870564 @default.
• W260545907 cites W58740590 @default.
• W260545907 doi "https://doi.org/10.1007/s13277-015-3506-z" @default.
• W260545907 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4605962" @default.
• W260545907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25946974" @default.
• W260545907 hasPublicationYear "2015" @default.
• W260545907 type Work @default.
• W260545907 sameAs 260545907 @default.
• W260545907 citedByCount "40" @default.
• W260545907 countsByYear W2605459072016 @default.
• W260545907 countsByYear W2605459072017 @default.
• W260545907 countsByYear W2605459072018 @default.
• W260545907 countsByYear W2605459072019 @default.
• W260545907 countsByYear W2605459072020 @default.
• W260545907 countsByYear W2605459072021 @default.
• W260545907 countsByYear W2605459072022 @default.
• W260545907 countsByYear W2605459072023 @default.
• W260545907 crossrefType "journal-article" @default.
• W260545907 hasAuthorship W260545907A5000899916 @default.
• W260545907 hasAuthorship W260545907A5010799497 @default.
• W260545907 hasAuthorship W260545907A5014711416 @default.
• W260545907 hasAuthorship W260545907A5019040298 @default.
• W260545907 hasAuthorship W260545907A5075727656 @default.
• W260545907 hasAuthorship W260545907A5088703623 @default.
• W260545907 hasAuthorship W260545907A5089571215 @default.
• W260545907 hasBestOaLocation W2605459071 @default.
• W260545907 hasConcept C121608353 @default.
• W260545907 hasConcept C126322002 @default.
• W260545907 hasConcept C143998085 @default.
• W260545907 hasConcept C146357865 @default.
• W260545907 hasConcept C151730666 @default.
• W260545907 hasConcept C181199279 @default.
• W260545907 hasConcept C2775975398 @default.
• W260545907 hasConcept C2780391879 @default.
• W260545907 hasConcept C502942594 @default.
• W260545907 hasConcept C55493867 @default.
• W260545907 hasConcept C71924100 @default.
• W260545907 hasConcept C75520062 @default.
• W260545907 hasConcept C86803240 @default.
• W260545907 hasConceptScore W260545907C121608353 @default.
• W260545907 hasConceptScore W260545907C126322002 @default.
• W260545907 hasConceptScore W260545907C143998085 @default.
• W260545907 hasConceptScore W260545907C146357865 @default.
• W260545907 hasConceptScore W260545907C151730666 @default.
• W260545907 hasConceptScore W260545907C181199279 @default.
• W260545907 hasConceptScore W260545907C2775975398 @default.
• W260545907 hasConceptScore W260545907C2780391879 @default.
• W260545907 hasConceptScore W260545907C502942594 @default.
• W260545907 hasConceptScore W260545907C55493867 @default.
• W260545907 hasConceptScore W260545907C71924100 @default.
• W260545907 hasConceptScore W260545907C75520062 @default.
• W260545907 hasConceptScore W260545907C86803240 @default.
• W260545907 hasIssue "10" @default.

• next